Patents Assigned to Adepthera LLC
  • Peptide analogs
    Patent number: 12110318
    Abstract: Analogs for CLR/RAMP receptor ligands are provided that have agonist, superagonist, antagonist, super-antagonist, or multiple receptor modulating activity. The analogs can be selective for one or more CLR/RAMP receptors, or can be pan-specific for multiple G protein-coupled receptors.
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: October 8, 2024
    Assignee: Adepthera LLC
    Inventor: Sheau Yu Teddy Hsu
  • Dosing and use of long-acting CLR/ramp agonists
    Patent number: 11701409
    Abstract: Long-acting agonistic analogs for CLR/RAMP receptors are provided that have an extended half-live in vivo. The agonists are delivered to an individual at a dose sufficient to reduce hypertension and ischemic injury, and to reduce cardiotoxicity associated with chemotherapeutic agents.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: July 18, 2023
    Assignee: Adepthera LLC
    Inventor: Sheau Yu Teddy Hsu
  • Peptide analogs
    Patent number: 11390657
    Abstract: Analogs for CLR/RAMP receptor ligands are provided that have agonist, superagonist, antagonist, super-antagonist, or multiple receptor modulating activity. The analogs can be selective for one or more CLR/RAMP receptors, or can be pan-specific for multiple G protein-coupled receptors.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: July 19, 2022
    Assignee: Adepthera LLC
    Inventor: Sheau Yu Teddy Hsu
  • Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormones
    Patent number: 11034745
    Abstract: Analogs for CLR/RAMP receptor ligands are provided that have agonist, superagonist, antagonist or superantagonist activity. The analogs can be selective for one or more CLR/RAMP receptors, or can be pan-specific.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: June 15, 2021
    Assignee: Adepthera LLC
    Inventor: Sheau Yu Teddy Hsu